NPPA and Parkinson disease: Even if further studies, aimed to demonstrate the neuroprotective effectiveness of this natriuretic peptide in animal models of PD, will be required, these results indicate that modulation by ANP of Wnt/β-catenin signaling in neuron cells, and in particular in mDA neurons, could be an innovative approach for PD treatment, and represent a possible starting point for future clinical applications.